Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
OVERLAP
30%
OVERLAP
BY WEIGHT
45
# OF OVERLAPPING
HOLDINGS
XGEN.DE
100
HOLDINGS
48%
ALSO IN BTEE.L
BTEE.L
272
HOLDINGS
20%
ALSO IN XGEN.DE
SECTOR DRIFT (XGEN.DE minus BTEE.L)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XGEN.DE |
Weight in BTEE.L |
Overlap | |
|---|---|---|---|---|
 |
VERTEX PHARMACEUTICALS INC | 4.4% | 8.7% | 4.4% |
|
INSMED INC | 3.5% | 2.5% | 2.5% |
|
ALNYLAM PHARMACEUTICALS INC | 2.4% | 3.6% | 2.4% |
 |
ARGENX SE ADR | 3.1% | 1.8% | 1.8% |
|
ILLUMINA INC | 4.3% | 1.8% | 1.8% |
XGEN.DE Overweight Relative to BTEE.L
|
NATERA INC | 5.0% |
 |
ROCHE HOLDING LTD | 4.9% |
|
ROCHE HOLDING AG-GENUSSCHEIN | 4.9% |
|
DANAHER CORP | 4.7% |
|
ELI LILLY & CO | 4.4% |
|
LONZA GROUP AG-REG | 4.4% |
|
ABBOTT LABORATORIES | 4.1% |
|
AGILENT TECHNOLOGIES INC | 4.1% |
 |
WUXI BIOLOGICS (CAYMAN) INC. | 2.7% |
|
PERKINELMER INC | 2.6% |
XGEN.DE Underweight Relative to BTEE.L
|
GILEAD SCIENCES INC | -8.4% |
|
AMGEN INC | -8.1% |
|
REGENERON PHARMACEUTICALS | -5.8% |
|
VERTEX PHARMACEUTICALS INC | -4.3% |
|
BIOGEN IDEC INC | -1.9% |
|
REVOLUTION MEDICINES, INC. | -1.7% |
|
INCYTE CORP | -1.5% |
|
UNITED THERAPEUTICS CORP | -1.5% |
|
ROYALTY PHARMA PLC CLASS A | -1.3% |
|
ALNYLAM PHARMACEUTICALS INC | -1.2% |